SCHEMBL1490627

SCHEMBL1490627

O=C(Nc1csc(-c2ccccc2Br)c1C(=O)O)c1cccc(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
POLB P06746 3/20 0.49
MAPT P10636 2/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
KCNK3 O14649 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
TSHR P16473 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HPGD P15428 1/20 0.42
GPR35 Q9HC97 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490529 0.88 MEN1 (0.53) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490618 0.87 CASP3 (0.54) MEN1KMT2APOLBMAPTKCNK3
SCHEMBL1490367 0.83 MEN1 (0.50) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490505 0.83 KMT2A (0.46) MEN1KMT2APOLBMAPTRAB9A
SCHEMBL3628701 0.81 MEN1 (0.57) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490371 0.81 KMT2A (0.47) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL1490422 0.81 L3MBTL1 (0.46) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12830504 0.81 MEN1 (0.45) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL15480685 0.80 MEN1 (0.54) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490346 0.79 MEN1 (0.50) MEN1KMT2APOLBMAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MEN1 2958/4885KMT2A 4706/4885POLB 4774/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MEN1 2958/4885KMT2A 4706/4885POLB 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.